BEAM THERAPEUTICS INC

Beam Therapeutics’ current market snapshot: $23.84, 2.6B cap, 52‑week highs/lows. Dive into recent DNA‑editing biotech trends.

Beam Therapeutics (BEAM) trades near its 200‑day SMA, showing consolidation while awaiting new clinical data and regulatory updates—a key insight for long‑term investors.

Beam Therapeutics stock rises 3% to $24.84—see latest price, volume, market cap, and peer comparison.